Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPAC: OMIP for Asthma Prevention in High-Risk Children
NCT00346398Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2006
- Primary completion
- Jul 2011
- Modality
- Allergy Immunotherapy
- Countries
- 2
01
Overview
A Phase 2 trial of phleum pratense extract, Standardized allergenic extract, cat hair, House dust mite allergen extract in asthma, sponsored by National Institute of Allergy and Infectious Diseases. Started May 2006; status: completed.
02
Drugs
phleum pratense extractStandardized allergenic extract, cat hairHouse dust mite allergen extract
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00346398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346398.